resistanceBio
resistanceBio is a startup headquartered in Menlo Park, United States, founded in 2021. It has raised at least $12.8m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
resistanceBio has raised at least $12.8m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
resistanceBio sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in Menlo Park
- AecorBio
- Aha!
- Altera.AL
- Arkenstone Defense
- Attotude
- Avenue Biosciences Holding
- Clear Labs
- Develop Health
- Diffbot
- Elea.ai
- GOQii
Related
- Innovation profile of Menlo Park
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does resistanceBio do?
resistanceBio is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has resistanceBio raised?
At least $12.8m, according to its Form D filings with the US Securities and Exchange Commission.
Where is resistanceBio based?
resistanceBio is headquartered in Menlo Park, United States.
When was resistanceBio founded?
resistanceBio was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.